Barclays PLC Insmed Inc Put Options Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $347,220 - $404,190	13,500 New	13,500 $366,000
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $10,843 - $18,046	-700 Reduced 30.43%	1,600 $28,000
Q2 2019 Aug 14, 2019	SELL	$23.0 - $32.19 $2.26 Million - $3.16 Million	-98,100 Reduced 97.71%	2,300 $59,000
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $5,564 - $12,460	400 Added 0.4%	100,400 $2.92 Million
Q4 2018 Feb 14, 2019	BUY	$11.6 - $18.7 $1.16 Million - $1.87 Million	99,900 Added 99900.0%	100,000 $1.31 Million
Q1 2018 May 15, 2018	SELL	$21.69 - $32.99 $1.77 Million - $2.7 Million	-81,700 Reduced 99.88%	100 $2,000
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $949,698 - $2.55 Million	81,800	81,800 $2.55 Million

480

182M

2.27M

3.32M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $11B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.